Cardiology Online

Home

Welcome

Scientific Committees

Final Program  

Final Program (as a pdf) 

Program at a Glance(as a .doc) 

IAC Awards

IAC Distinguished Fellowships

Timetable

Participant Letter

Program Topics

General Information

Abstract Guidelines

Abstract Form

Instructions for the Preparation of Posters

Registration Form

Accommodation

Accommodation Form

Exhibition

Photos

Contact Us

Click here for Writing Instructions &
Sending your Article(s)
to Monduzzi Editore -
Medimond's Proceeding Book

 

 


 

Sunday,
July 29, 2007
Monday,
July 30, 2007
Tuesday,
July 31, 2007
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Sunday, July 29, 2007

09:00 - 10:15   HALL A
 9:00 OC OPENING CEREMONY
Chairperson: J.S. Borer, New York, NY, USA

 GREETINGS
  
Asher Kimchi, USA
  Founder and Chairman
  International Academy of Cardiology
  13th World Congress on Heart Disease

  Jeffrey S. Borer, USA
  Chairman, Scientific Executive Committee
  Chairman, Section of Valvular Heart Disease
  International Academy of Cardiology
  13th World Congress on Heart Disease

  Naranjan S. Dhalla, Canada
  Member, Scientific Executive Committee
  Chairman, Section of Cellular Biology of the Heart
  International Academy of Cardiology
  13th World Congress on Heart Disease

  John A. Elefteriades, USA
  Member, Scientific Executive Committee
  Chairman, Section of Cardiovascular Surgery
  International Academy of Cardiology
  13th World Congress on Heart Disease

  Uri Elkayam, USA
  Member, Scientific Executive Committee
  Chairman, Section of Heart Failure
  International Academy of Cardiology
  13th World Congress on Heart Disease

 

 PRESENTATION OF 2007 AWARDS

     Jeffrey S. Borer, USA

 
09:35 - 10:15  OL OPENING LECTURE -
 
SECOND H.J.C. SWAN MEMORIAL LECTURE

 Chairperson:
U. Elkayam, Los Angeles, CA, USA
HALL A
9:35 INTRODUCTION
U. Elkayam, Los Angeles, CA, USA 
 
9:40

HOW BEST TO IDENTIFY PATIENTS AT RISK FOR SUDDEN CARDIAC DEATH (Invited Lecture)
M.E. Cain, University at Buffalo, Buffalo, NY, USA  

 
10:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2007
10:45-13:30   HALL A
  PL01    Plenary Session:
CARDIAC REPAIR AND REGENERATION
 
Chairpersons:    J.D. Marsh, Little Rock, AR, USA
                        T. Toyo-oka, Sendai, Japan
 
10:45 STEM CELLS AND VASCULAR DISEASES (Invited Lecture)
Q. Xu,
A. Zampetaki, Cardiovascular Division, King’s College London, London, UK
 1
11:00 LONG-LASTING PLASTICITY OF SLOW-TWITCH SKELETAL MYOBLASTS FOR SELECTIVE ENGRAFTMENT AND FUNCTIONAL IMPROVEMENT OF FAILING HEART (Invited Lecture)
T. Toyo-oka
, A. Tezuka, T. Kawada, M. Nakazawa, F. Masui, S. Konno, S. NittaTokyo University. Hospital, & TUBERO, Sendai, Japan 
 2
11:15 MODIFICATION OF CARDIOVASCULAR ION CHANNELS BY GENE THERAPY (Invited Lecture)
J.D. Marsh,
University of Arkansas for Medical Sciences, Little Rock, AR, USA
 3
11:30 HUMAN CARDIOMYOCYTE PROGENITOR CELLS DIFFERENTIATE INTO FUNCTIONAL CARDIOMYOCYTES IN VITRO (Invited Lecture)
M-J.Goumans, T.P. de Boer, A.M. Smits, L.W. van Laake, J.P.G. Sluijter,
P. van Vliet, M.A.G. van der Heyden, G.Pasterkamp, C. L. Mummery, T.A.B. van Veen, P.A. Doevendans, University Medical Center, Heidelberglaan, The Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
 4
11:45 UNLOCKING THE MYSTERIES THAT GOVERN VASCULAR CELL LIFE AND CELL LONGEVITY (Invited Lecture)
K. Maiese, Z.Z. Chong, Wayne State University, Detroit, MI, USA
 5
12:00 SKELETAL MYOBLASTS FOR CHRONIC HEART FAILURE (Invited Lecture)
P.C. Smits, Medisch Centrum Rijnmond Zuid, Rotterdam, Netherlands
 6
12:15 LABELING OF STEM CELLS FOR NONINVASIVE DELIVERY AND TRACKING IN CARDIOVASCULAR REGENERATIVE THERAPY (Invited Lecture)
D. Kraitchman, Johns Hopkins University, Baltimore, MD, USA
 7
12:30 MYOCARDIAL RESTORATION WITH STEM CELLS AND BIOARTIFICIAL TISSUES; PANDORA'S BOX ON THE SCALE (Invited Lecture)
T. Kofidis, National University of Singapore, Singapore
 8
12:45 NOVEL ENDOGENOUS MYOCARDIAL REPAIR STRATEGIES FOR THE TREATMENT OF HEART FAILURE (Invited Lecture)
Y.J. Woo, University of Pennsylvania, Philadelphia, USA
 9
13:00 SYSTEMIC INFLAMMATORY CHANGES AND PROGENITOR CELL  MOBILIZATION IN ACUTE MYOCARDIAL INFARCTION (Invited Lecture) 
I. Ott, Deutsches Herzzenrum, Munich, Germany
 10
13:15 REGULABLE GENE EXPRESSION SYSTEM FOR ISCHEMIC MYOCARDIUM
W. Zhang, L.P. Su, L. Ye, E. Sim, National Heart Center, Singapore
 11
13:30 LUNCH BREAK  
SUNDAY, JULY 29, 2007
10:45-12:15   HALL B
 

 

PL02   Plenary Session:
TREATMENT OF CAROTID STENOSIS AND PERIPHERAL VASCULAR DISEASE
Chairpersons:    G.A. Stouffer, Chapel Hill, NC, USA
                       
T. Tomaru, Sakura City, Japan
 

 

10:45

EMBOLIC PROTECTION DURING CAROTID STENTING WITH THE NEW FIBERNET DEVICE (Invited Lecture)
H. Sievert, J. Franke, C.Bauer, V.Woerner, N. Wunderlich, K. Mathias, J. Schofer, CardioVascular Center Frankfurt, Germany, Washington Hospital DC, USA

 12
11:00 APPLICATION OF ANGIOSCOPY FOR DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM (Invited Lecture)
T. Tomaru, Toho University Sakura Hospital, Chiba, Japan 
 13
11:15 NEW INSIGHTS INTO PERIPHERAL ARTERIAL DISEASE (Invited Lecture)
M.H. Criqui, University of California, SD, La Jolla, CA, USA 
 14
11:30 THE CHANGING PARADIGM OF RENAL ARTERY STENOSIS (Invited Lecture)
A. Pathak, M. Rojas, G.A. Stouffer,
University of North Carolina, Chapel Hill, NC, USA
 15
11:45 INTER-RELATIONSHIP OF CORONARY ARTERY DISEASE AND PERIPHERAL ARTERIAL DISEASE (Invited Lecture)
V. Mathew, Mayo Clinic, Rochester, MN, USA
 16
12:00  CAROTID ANGIOPLASTY UNDER PROTECTION. LIMITATIONS. NEW DEVELOPMENTS (Invited Lecture)
M. Henry, A. Polydorou, I. Henry, A. Polydorou, M. Hugel, Cabinet de Cardiologie, Nancy, France
 17
12:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2007
10:45 - 13:30   HALL C
  PL03   Session:  
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
Chairpersons:    N.S. Dhalla, Winnipeg, MB, Canada
                       
F.G. Spinale, Charleston, SC, USA
 
10:45 Beneficial effects of sarpogrelate (an antiplatelet agent) in congestive heart failure (Invited Lecture)
N.S. Dhalla, S.K. Sanganalmath, St. Boniface General Hospital Research Centre, Winnipeg, Canada 
 21
11:00 DIFFERENTIAL MATRIX METALLOPROTEINASE PROTEOMIC PROFILING IN PATIENTS AT RISK FOR HEART FAILURE: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS (Invited Lecture)
F.G. Spinale, Medical University of South Carolina, Charleston, SC, USA
 22
11:15 PLEIOTROPIC EFFECTS OF CARDIAC DRUGS AND INTERVENTIONS ON THE EXTRACELLULAR COLLAGEN MATRIX: THE GOOD, BAD AND UGLY (Invited Lecture)
B.I. Jugdutt, University of Alberta, Edmonton, Alberta, Canada
 23
11:30 HEAT SHOCK PROTEIN 60 IN HEART FAILURE: FRIEND OR FOE? (Invited Lecture)
L Lin, S.C. Kim, S. Gupta, S.I. Simon, A.A. Knowlton,
University of California, Davis, VA Medical Center, Sacramento, CA, USA,
 24
11:45 NATRIURETIC PEPTIDES IN THE APPROACH TO HEART FAILURE (Invited Lecture)
P. Bettencourt, Unidade Cuidados Intermedios Medicina Hospital, Lisbon, Portugal
 25
12:00 SERIAL BIOMARKER MEASUREMENTS (TROPONIN T AND B-TYPE NATRIURETIC PEPTIDE) IN AMBULATORY PATIENTS WITH CHRONIC HEART FAILURE--WHAT HAPPENS OVER TIME (Invited Lecture)
W.L. Miller, K.A. Hartman, D.E. Grill, J.C. Burnett, A.S. Jaffe, Mayo Clinic, Rochester, MN, USA
 26
12:15 RISK ASSESSMENT IN HEART FAILURE (Invited Lecture)
J. Butler, Emory University, Atlanta, GA, USA
 27
12:30 CAN NT-PROBNP LEVELS HELP PREVENT CARDIOVASCULAR DISEASE (Invited Lecture)
D.J. Campbell, M. Woodward, J.P. Chalmers, S.A. Colman, A.J. Jenkins, B.E. Kemp, A. Patel, B.C. Neal, S.W. MacMahon, St. Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia
 28
12:45 OBESITY AND HEART FAILURE:  EPIDEMIOLOGICAL CONFUSION AND DIAGNOSTIC DILEMMAS (Invited Lecture)
H. Dokainish, Baylor College of Medicine, Houston, TX, USA
 29
13:00 MEASURING THE QUALITY OF HEART FAILURE CARE (Invited Lecture)
P.A. Heidenreich, Palo Alto VA Health Care System, Palo Alto, CA, U.S.A.
 30
13:15 CHRONIC APELIN ADMINISTRATION PREVENTS THE DEVELOPMENT OF LV REMODELING AND DYSFUNCTION IN RATS WITH HEART FAILURE
Y. Iwanaga, Y. Tamaki, T. Kita, Kyoto University, Kyoto, Japan
 31
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2007
10:45 - 13:45   HALL D
  S51   Session:  
ATHEROSCLEROSIS: PRIMARY PREVENTION, DIABETES MELLITUS, OBESITY, METABOLIC SYNDROME
Chairpersons:    H. Lazar, Boston, MA, USA 
                        N.D. Wong, Irvine, CA, USA
 
10:45 ACUTE CORONARY SYNDROMES AND DIABETES: IS INTENSIVE LIPID LOWERING BENEFICIAL? RESULTS OF THE PROVE IT –TIMI 22 TRIAL
S. Ahmed, C.P. Cannon, S.A. Murphy, E. Braunwald, Sunnybrook Health Sciences Centre University of Toronto, Canada
 32
 11:00 ROLE OF CALRETICULIN IN INDUCING ENDOTHELIAL CELLS DYSFUNCTION IN DIABETES
Y. Riahi, H. Totary-Jain, S. Sasson, Hebrew University of Jerusalem, Israel
 33
11:15 HEME OXYGENASE-1 (HO-1) INHIBITS THE DEVELOPMENT OF MYOCARDIAL DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC CARDIOMYOPATHY IN MOUSE  
S. Kiuchi, T. Morita, T. Suzuki, Y. Yamagishi, J. Tatebe, J. Yamasaki, Toho University, Japan
 34
11:30 IMPACT OF DIABETES ON DISPARITIES IN THE DECLINE OF CARDIOVASCULAR DEATH RATES: US, 1993 AND 2003
J. Fang, M.H. Alderman, C. Ayala, N.L. Keenan, J.B. Croft, Division for Heart Disease and Stroke, CDC, Atlanta, GA, USA
 35
11:45 GENDER SPECIFIC PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN LATIN AMERICA: RESULTS FROM LASO
L.E. Bautista, V.M. Herrera, J.P. Casas, M. Orostegui, N. Schapochnik, C. Ferreccio, L. Rosero, R. Pichardo, J.R. Sanchez, E. Silva, University of Wisconsin, Madison, WI, USA
 36
12:00 PREDICTING CHD/IHD DEATH: METABOLIC SYNDROME VS. FRAMINGHAM SCORE: THE RANCHO BERNARDO STUDY
E. Barrett-Connor, H. Araneta, University of California, San Diego, La Jolla, CA, USA
 37
 12:15 ASSOCIATIONS OF BLOOD LEVELS OF INSULIN-LIKE GROWTH FACTOR (IGF)-I, IGF-II AND IGF-BINDING PROTEIN (IGFBP)-3 WITH CORONARY HEART DISEASE IN ARAB SUBJECTS
K. Kapila, A.O. Akanji, Faculty of Medicine, Kuwait University, Kuwait
 38
12:30 EFFECT OF ROSIGLITAZONE TREATMENT ON POSTPRANDIAL ENDOTHELIAL DYSFUNCTION INDICES IN PATIENTS WITH TYPE 2 DIABETES 
S. Pastromas,
S. Koulouris, D. Sakellariou, G. Ioannidis, D. Tyousoulis, N. Zakopoulos, A. Nikou, Ch. Stefanadis, A.S. Manolis, Evagelismos General Hospital Athens, Athens
 39
12:45 MODERATE OR SEVERE RENAL INSUFFICIENCY IS ASSOCIATED WITH 3-VESSEL CORONARY ARTERY DISEASE
O. Khalique, W.I.S. Aronow, C. Ahn, M. Mazar, B. Schair, J. Shao, V. Channamsetty, New York Medical College, Valhalla, NY, USA
 40
13:00 ACUTE OUTCOME AND LONG-TERM RESULTS OF CAROTID STENTING UP TO 11 YEARS: A COMPARISON OF DIABETIC AND NON-DIABETIC PATIENTS  
J. Franke, V. Woerner, C. Bauer, S. Ghasemzadeh-Asl, M. Koch, C. Thomalske, U. Oetjen, P. Schneider, N. Wunderlich, H. Sievert, CardioVascular Center Frankfurt, Germany
 41
13:15 EPICARDIAL ADIPOSE TISSUE IS RELATED TO CAROTID INTIMA-MEDIA THICKNESS AND VISCERAL ADIPOSITY IN HIV- INFECTED PATIENTS WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY-ASSOCIATED METABOLIC SYNDROME
G. Iacobellis, A.M. Pellicelli, B. Grisorio, G. Barbarini, A.M. Sharma, G. Barbaro,
Policlinico S.Matteo, Pavia, Italy
 42
 13:30 EFFECTS OF ACE2 GENE TRANSFER ON THE EXPRESSION OF MIF IN HUMAN ENDOTHELIAL CELLS
J.C. Zhong, X.Y. Yu, X.H. Li, Q.X. Lin, X.Z. Huang, S.G. Lin, Guangdong Provincial People’s Hospital, Guangzhou, Guangdong, China
 43
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 29, 2007
14:00 - 16:15   HALL A
  PL04   Plenary Session:
RISK STRATIFICATION FOR SUDDEN CARDIAC DEATH
Chairpersons:     M. Cain, Buffalo, NY, USA
                         J.E. Madias, Elmhurst, NY, USA
 
14:00 REPRODUCIBILITY OF T-WAVE ALTERNANS IN PATIENTS WITH CHF (Invited Lecture)
J. Madias, Mount Sinai School of Medicine of the New York/Cardiology Division, Elmhurst Hospital Center, USA  
 107
14:15 PUBLIC ACCESS DEFIBRILLATION IN OUT-OF-HOSPITAL CARDIAC ARREST THE PIACENZA PROGETTO VITA RESULTS
A. Capucci, D. Aschieri, G.Q. Villani, M. Piepoli, A. Rosi, M.S. Pisati, C. Armentano, Piacenza Hospital, Italy
 108
14:30 POPULATION-BASED ANALYSIS OF SUDDEN CARDIAC DEATH: CLINICAL IMPLICATIONS (Invited Lecture)
S.S. Chugh, Oregon Health & Science University, Portland, Oregon, USA
 109
14:45 FLUCTUATIONS OF ECG AND RISK STRATIFICATION IN BRUGADA SYNDROME (Invited Lecture)
M. Takagi, H. Tatsumi, Osaka City University Graduate School of Medicine, Osaka, Japan
 110
15:00 SUDDEN CARDIAC DEATH IN YOUNG INDIVIDUALS: CLINICAL AND GENETIC INVESTIGATION OF THE FAMILY (Invited Lecture)
P.P. McKeown, Royal Hospitals Trust and Queen's University, Belfast, UK
 111
15:15 SYNCOPE OF UNKNOWN ORIGIN: CONTROL OF THE DRUG THERAPY EFFICACY BY TILT TEST REPETITION (Invited Lecture)
D. Flammang, G. Chauveau, S. Mousi, Lyon University Hospital, Lyon, France
 113
15:30 IS IT POSSIBLE TO REDUCE HOSPITALIZATION COSTS FOR PATIENTS CONSIDERED AT RISK OF SERIOUS ARRHYTHMIAS? (Invited Lecture)
A. Martinez Rubio, S. Galan, M. Cazorla, E. Guillaumet, S. Ibars, E. Guilera, M. Bonastre, R. Baga, G. Gusi, I. Anguera, Hosp de Sabadell, Spain
 114
15:45 CURRENT PERSPECTIVES IN RISK STRATIFICATION FOR SUDDEN CARDIAC DEATH (Invited Lecture)
D. Wichterle, Institute for Clinical and Experimental Medicine, Prague, Czech Republic             
 115
16:00 OBESITY, PHYSICAL ACTIVITY AND SUDDEN CARDIAC ARREST
P.R. Reddy, K. Reinier, C. Socoteanu, R. Mariani, S.S. Chugh, Oregon Health and Science University, Portland, OR, USA
 116
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2007
14:00 - 16:15   HALL B
  PL05   Plenary Session:
NEW DEVELOPMENTS IN CARDIAC IMAGING
Chairpersons:     S. Dalla-Volta, Padova, Italy 
                       
  
 
14:00 A COMPARISON BETWEEN CORONARY ANGIOGRAM AND MULTISLICE CT IN CORONARY ARTERY DISEASE. A STUDY OF 150 CASES (Invited Lecture)
P. Greco, S. Romano, M. Del-Borrello, S. Dalla-Volta, with technical collaboration of Luigi Baracchino, Euganea Medica Cardiac Imaging Laboratory, Padova, Italy
 117
14:15

CONCERNING CORONARY ARTERY CALCIUM (Invited Lecture)
E. Barrett-Connor, University of California, San Diego (UCSD), La Jolla, CA, USA 

 119
14:30 CORONARY ARTERY BYPASS GRAFTS AND CT ANGIOGRAPHY (Invited Lecture)
L. Kritharides, Concord Hospital, University of Sydney, Australia
 120
14:45 

REAL-TIME 3D ECHOCARDIOGRAPHY 2007 (Invited Lecture)
F.J. Ten Cate, Erasmus MC, Rotterdam, The Netherlands

 121
15:00 MDCT OF CARDIOVASCULAR DISEASE: PRESENT STATUS & FUTURE PROSPECTS (Invited Lecture)
J. Lima, Johns Hopkins University, Baltimore, MD, USA
 122
15:15 THE FUTURE OF STRESS PERFUSION IMAGING IN THE ERA OF CT (Invited Lecture)
R. Hachamovitch, University of Southern California, Los Angeles, CA, USA
 123
15:30 REVASCULARIZATION IN LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: THE ROLE OF VIABILITY TESTING (Invited Lecture)
P. Chareonthaitawee, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN, USA
 124
15:45

ECHOCARDIOGRAPHY OF THE SUPERIOR VENA CAVA (SVC): CURRENT STATUS 2007
R.N. Khouzam, D. Minderman, I.A. D'Cruz, University of Tennessee Health Science Center, Memphis, TN, USA

 125
16:00 IMPROVED YIELD OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN STROKE PATIENTS IS MAINLY LIMITED TO AORTIC PLAQUE AND INTRACARDIAC SHUNT
D.M. Spevack, D. Malhotra, S. Doddamani, R.J. Ostfeld,
E. Altman, G.M. Gordon,
Montefiore Medical Center, Bronx, NY, USA 
 127
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION
SUNDAY, JULY 29, 2007
14:00 - 16:15   HALL C
  PL06   Plenary Session:
INFLAMMATION AND ATHEROGENESIS
Chairpersons:        J.G. Filep, Montreal, Canada
                           
I. Jialal, Sacramento, CA, USA   
                      
 
14:00 C-REACTIVE PROTEIN PROMOTES ATHEROTHROMBOSIS (Invited Lecture)
I. Jialal, UC Davis Medical Center, Sacramento CA, USA
 129
14:15 DOES C-REACTIVE PROTEIN ORCHESTRATE INFLAMMATION IN ACUTE CORONARY ARTERY DISEASE? (Invited Lecture)
J.G. Filep, L. Jozsef, L.A. Potempa, T. Khreiss, Maisonneuve-Rosemont Hospital, University of Montreal, QC, Canada
 130
14:30 THE INFLAMMATORY RESPONSE IN THE NEONATE AND ITS MANAGEMENT (Invited Lecture)
T.F. Feltes, Ohio State University, Columbus Children's Hospital, Ohio, USA
 131
14:45 IMMUNE RESPONSE TO OXLDL AND ITS IMPACT IN ATHEROSCLEROSIS (Invited Lecture)
X. Zhou, Karolinska Hospital, Stockholm, Sweden
 132
15:00

MOLECULAR IMAGING OF ATHEROSCLEROTIC PLAQUE INFLAMMATION (Invited Lecture)
M. Aikawa, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA 

 133
15:15 PROSTANOIDS AND ISOPROSTANOIDS IN ATHEROGENESIS (Invited Lecture)
D. Pratico, University of Pennsylvania, Philadelphia, USA
 134
15:30 ORIGIN OF LOW-GRADE SYSTEMIC INFLAMMATION (Invited Lecture)
D. Aronson, Rambam Medical Center, Haifa, Israel
 135
15:45 THE ROLE OF ANTIGEN-PRESENTING CELLS IN CARDIOVASCULAR DISEASE: A POTENTIAL THERAPEUTIC TARGET? (Invited Lecture)
A. Niessner, Medical University of Vienna, Austria
 136
16:00 CYBA C242T GENE POLYMORPHISM IS ASSOCIATED WITH THE LEVEL OF C-REACTIVE-PROTEIN (CRP) IN A POPULATION OF YOUNG HEALTHY FINNS
M. Fan, O.T. Raitakari, M. Kahonen, M. Juonala, N. Hutri-Kahonen, J. Marniemi, J. Viikari, T. Lehtimaki, Tampere University Hospital and Medical School at the University of Tampere, Finland
 137
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2007
14:00 - 16:30   HALL D
  S52  Session:
SECONDARY PREVENTION, MODIFICATION OF LIPOPROTEINS, PROGNOSIS, RISK STRATIFICATION
Chairpersons:    S-O. Olofsson, Goteborg, Sweden  
        
               R.S. Rosenson, Ann Arbor, MI, USA
 
14:00 DOSE-DEPENDENT REDUCTIONS IN LDL-C WITH ISIS 301012, AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN B
D.L. Tribble, M.K. Wedel, B.F. Baker, E. Stein, R. Fuhr, J.W. Jukema, E. Sijbrands, M. Trip, F. Visseren, R. Weiss, F. Akdim, J.J.P. Kastelein, Isis Pharmaceuticals Inc, Carlsbad, CA, USA
 138
14:15 STATIN USE BEFORE AND AFTER STROKE ONSET IMPROVES OUTCOME OF ACUTE ISCHEMIC STROKE
M. Moonis, K. Kane, M. Fisher, UMass Medical Center, Worcester, MA, USA
 139
14:30 GLOMERULAR FILTRATION RATE AT CARDIAC CATHETERIZATION PREDICTS FUTURE ADVERSE CARDIAC EVENTS
S.S. Brar, K. Ellini, V.J. Aharonian, P. Mansukhani, I.L. Liu, A.Y.J. Shen,
Kaiser Permanente Medical Center, Los Angeles, CA, USA
 140
14:45 IMPACT OF ROUTINE IN-HOSPITAL ASSESSMENT OF LDL LEVELS AND LIPID LOWERING THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
M. Ahmad, J-D.R. Schwalm, J.L.Velianou, M.K. Natarajan, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada
 141
15:00 RECURRENT ANGINA FOLLOWING REVASCULARIZATION 
J.A. Kempf, S. Shetty, M.A. Nelson, M. Sweeney, CV Therapeutics, Palo Alto, CA. USA
 142
15:15  BLUEBERRY-ENRICHED DIET PROTECTS HEART FROM ISCHEMIC DAMAGE
I. Ahmet, E. Spangler, B. Shukitt-Hale, J. Joseph, D.K. Ingram, M.I. Talan,
National Institute on Aging, Baltimore, MD, USA
 143
15:30 THE IMPACT OF SEXUAL THERAPY ON PATIENTS AFTER CARDIAC EVENTS PARTICIPATING IN MULTI-DISCIPLINARY CARDIAC REHABILITATION PROGRAM
J. Klein, R. Klein, E. Bar-on, R. Bebenishty, Shaare Zedek Medical Center, Jerusalem, Israel   
 144
15:45 COMPARATIVE EFFECT OF NITRATES AND TRIMETAZIDINE PLUS SILDENAFIL ON EXERCISE-INDUCED MYOCARDIAL ISCHEMIA.  IMPLICATIONS FOR PATIENTS WITH ERECTILE DYSFUNCTION
G. Marazzi, C. Vitale, M. Miceli, G. Caminiti, L.Gatta, C. Mammi, M. Volterrani, G. Rosano, IRCCS San
Raffaele Roma, Italy
 145
16:00 ACCURACY OF RATIO OF TRIGLYCERIDE TO HDL IN PREDICTING HDL PARTICLE SIZE IN ASIAN INDIANS
N.C. Bhalodkar, S Blum, R Singh, E.A. Enas, Albert Einstein College of Medicine, Bronx, NY, USA
 146
16:15 INFLAMMATORY PROTEINS AND DEPRESSION AFTER CORONARY STENTING PREDICT MAJOR ADVERSE CORONARY EVENTS
L. Frazier, W.K. Vaughn, J.T. Willerson, C.M.  Ballantyne, E. Boerwinkle, University of Texas at Houston, Texas, USA
 147
16:30 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 29, 2007
16:45-19:15   HALL A
  PL07   Plenary Session:
NEW CONCEPTS IN TRANSLATIONAL CARDIAC RESEARCH
Chairpersons:    J. Nilsson, Malmo, Sweden
                        R. Roberts, Ottawa, ON, Canada 
 
16:45 PURSUING GENES THAT CONTRIBUTE TO CORONARY ARTERY DISEASE – AN IDEA WHO’S TIME HAS COME (Invited Lecture)
R. Roberts, University of Ottawa Heart Institute, Ontario, Canada
 150
17:00 LIPOPROTEIN AUTOIMMUNITY AS A NOVEL TARGET FOR TREATMENT OF CARDIOVASCULAR DISEASE (Invited Lecture)
J. Nilsson, Lund University, Malmo, Sweden
 151
17:15 CLINICAL GENOMIC AND PROTEOMIC APPROACHES TO UNDERSTAND CARDIOVASCULAR DISEASE (Invited Lecture)
C. Patterson,
University of North Carolina at Chapel Hill, NC, USA
 152
17:30 STRUCTURAL BIOLOGICAL APPROACH TO CARDIOVASCULAR DISEASE (Invited Lecture)
H. Mori, National Cardiovascular Center Research Institute, Suita, Osaka, Japan
 153
17:45 SELECTIVE NUCLEAR RECEPTOR MODULATION IN CARDIOMETABOLIC DISEASE (Invited Lecture)
U. Kintscher, Charite-Universitaetsmedizin Berlin, Germany
 154
18:00 COMPREHENSIVE APPROACHES FOR IDENTIFICATION OF SUSCEPTIBILITY GENES TO MYOCARDIAL INFARCTION (Invited Lecture)
M. Yokota, Aichi-Gakuin University, Nagoya, Japan
 155
18:15 PARALLELS BETWEEN THE NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES (Invited Lecture)
J. Robbins, Cincinnati Children's Hospital, OH, USA
 156
18:30 PHARMACOLOGICAL INHIBITION OF EPSILON PKC PREVENTS THE PROGRESSION OF HYPERTENSION-INDUCED HEART FAILURE IN RATS (Invited Lecture)
K. Inagaki, T. Koyanagi, D. Mochly-Rosen, Stanford University School of Medicine, Stanford, CA, USA       
 157
18:45 ENDOGENOUS SECRETORY RAGE: A POTENTIAL TARGET FOR CARDIOVASCULAR DISEASES AND METABOLIC SYNDROME (Invited Lecture)
H. Koyama, H.Yamamoto, Y. Nishizawa, Osaka City University Graduate School of Medicine, Osaka, Japan
 159
19:00 MOLECULAR IMAGING IN CARDIOVASCULAR DISEASES (Invited Lecture)
E. Aikawa, Massachusetts General Hospital and Harvard Medical School, MA, USA
 160
SUNDAY, JULY 29, 2007
16:45 - 19:30   HALL B
  PL08   Plenary Session:
MODIFICATION OF RISK FACTORS AND CAD, DYSLIPOPROTEINEMIA, HYPERTENSION, DIABETES MELLITUS AND METABOLIC SYNDROME
Chairpersons:    H. Boudoulas, Athens, Greece
                        C. Rosendorff, Bronx, NY, USA
 
16:45 HOW LOW IS TOO LOW? IS THERE A LIMIT TO BLOOD PRESSURE LOWERING? (Invited Lecture)
C. Rosendorff, Mount Sinai School of Medicine and the JJ Peters VA Medical Center, New York, NY, USA
 161
17:00 ASSOCIATION BETWEEN GLYCOSYLATED HEMOGLOBIN, LEFT VENTRICULAR MASS AND AORTIC FUNCTION IN NON DIABETIC INDIVIDUALS WITH INSULIN RESISTANCE (Invited Lecture)
H. Boudoulas, Biomedical Research Foundation, Academy of Athens, Greece
 162
17:15 VASCULAR SIGNALING IN HYPERTENSION - CURRENT CONCEPTS AND FUTURE (Invited Lecture)
R.M. Touyz, Ottawa Health Research Institute, University of Ottawa, Ottawa, ON, Canada
 163
17:30 IMPACT OF METABOLIC SYNDROME ON LEFT VENTRICULAR MASS AND GEOMETRY IN YOUNG ADULTS: THE BOGALUSA HEART STUDY (Invited Lecture)
D.A. Patel, S.R. Srinivasan, W. Chen, E. McIlwain, G.S. Berenson,
Tulane Center for Cardiovascular Health, Tulane University, New Orleans, LA, USA
 164
17:45 LIPID STORAGE IN CELLS; MECHANISM AND IMPLICATIONS FOR CARDIOVASCULAR DISEASES (Invited Lecture)
S.O. Olofsson, Department of Medicine, Goeteborg, Sweden
 165
18:00 BENEFITS OF TIGHT GLYCEMIC CONTROL DURING CORONARY REVASCULARIZATION (Invited Lecture)
H.L. Lazar, Boston Medical Center, MA, USA
 166
18:15
 
METABOLIC SYNDROME, SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK (Invited Lecture)
N.D. Wong, University of California, Irvine, CA, USA
 167
18:30
 
TARGETING LIPOPROTEIN SUBCLASS ABNORMALITIES IN THE METABOLIC SYNDROME:  NEW OPPORTUNITIES FOR CARDIOVASCULAR RISK REDUCTION
R.S. Rosenson, University of Michigan, Ann Arbor, MI, USA
 168
18:45 AGGRESSIVE LIPID MANAGEMENT: LDL APHERESIS (Invited Lecture)
D. Polk, Division of Cardiology Cedars-Sinai Medical Center, Los Angeles, CA, USA
 169
19:00 CLINICAL GUIDELINES FOR THE PRIMARY PREVENTION OF HYPERTENSION: CAN WE DO MORE? (Invited Lecture)
H.D. Sesso, Brigham and Women's Hospital, Boston, MA, USA
 170
19:15 MEDITERRANEAN DIET AND CORONARY HEART DISEASE, IS OBESITY A LINK? (Invited Lecture)
D.B. Panagiotakos, Harokopio University of Athens, Greece
 172
SUNDAY, JULY 29, 2007
16:30 - 19:15   HALL C
  S53  Session:
NEW INSIGHTS INTO THE PATHOGENESIS AND MANAGEMENT OF HEART FAILURE, PULMONARY CIRCULATION ASPECTS
Chairpersons:    T. Force, Philadelphia, PA, USA 
               
        B.I. Jugdutt, Edmonton, Alberta,
                          Canada
 
16:30 PULMONARY ARTERIAL HYPERTENSION (PAH) IN MICE LACKING THE VASOACTIVE INTESTINAL PEPTIDE (VIP) GENE
S.I. Said, S.A. Hamidi, K.G. Dickman, A.M. Szema, S. Lyubsky, R.Z. Lin, Y.P. Jiang, J.J. Chen, J.A. Waschek, S. Kort, SUNY at Stony Brook, Stony Brook, NY and VA Medical Center, Northport, NY, USA
 173
16:45 THE EFFECT OF INHALED MILRINONE ON PULMONARY HYPERTENSION IN PATIENTS UNDERGOING CARDIAC SURGERY, A PILOT RANDOMIZED STUDY
A.Y. Denault, F. Haddad, Y. Lamarche, P. Couture, J.C. Tardif, L. Perrault,
Montreal Heart Institute, Montreal, Quebec, Canada
 174
17:00 SINUS TACHYCARDIA PREDICTS INCREASED MORTALITY IN CHRONICALLY TREATED HEART FAILURE PATIENTS
C.A. Dragstedt, D.F. Pauly, R.S. Schofield, J.A. Hill, J.M.A. Aranda Jr., University of Florida College of Medicine, Gainesville, FL, USA
 175
17:15 REDUCTION OF GAP JUNCTION PROTEINS AND INTERCALATED DISC STRUCTURAL REMODELING IN THE HEARTS OF MICE SUBMITTED TO SEPSIS
M.R. Nunes-Celes, D. Tores-Dueñas, F.Q. Cunha, M.A. Rossi, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
 176
17:30 STATINS AND WHITE BLOOD CELL COUNT PREDICT MORTALITY IN PATIENTS WITH ISCHEMIC LEFT VENTRICULAR DYSFUNCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
M.J. Lipinski, A. Abbate, M.J. Cowley, E. Goudreau, W.N. Malloy, G.W. Vetrovec, University of Virginia Health System and Virginia Commonwealth University Health System, VA, USA
 177
17:45  “SHIFT”: HEART RATE SLOWING FOR HEART FAILURE
J.S. Borer, Weill Medical College of Cornell University, New York, NY, USA
 178
18:00 THE EFFECT OF HEMODIALYSIS SESSION ON P WAVE DISPERSION IN PATIENTS WITH CHRONIC HEMODIALYSIS
B. Ozben, M. Sumerkan, S.U. Kefeli, A.S. Fak, A.Toprak, M. Koc, N. Papila, M.A. Tanrikulu, A.O. Baykan, A.A. Cincin,
Marmara University Faculty of Medicine, Istanbul, Turkey
 179
18:15 RESULTS OF RADICAL RESECTION OF PRIMARY MAIN PULMONARY ARTERY SARCOMA
S.H. Blackmon, D.C. Rice, A.M. Correa, D.A. Ott, J.B. Putnam, W.R. Smythe, A.A. Vaporciyan, J.C. Walkes, G.L. Walsh, M.J. Reardon, The Methodist Hospital and M.D. Anderson Cancer Center, Texas, USA
 180
18:30  PROGNOSTIC VALUE OF PACING-INDUCED MECHANICAL ALTERNANS IN PATIENTS WITH MILD TO MODERATE IDIOPATHIC DILATED CARDIOMYOPATHY IN SINUS RHYTHM
A. Hirashiki, H. Izawa, T. Murohara, M.Yokota, Nagoya University Graduate School of Medicine, Nagoya, Japan
 181
18:45 FABRY’S DISEASE: CORONARY SMALL VESSEL OBSTRUCTION AS A CAUSE OF MYOCARDIAL ISCHEMIA AND DISEASE PROGRESSION
C. Chimenti, E. Morgante, G. Tanzili, R. Verardo, F. Toscano, C. Gaudio, M.A. Russo, A. Frustaci, La Sapienza University, Rome, Italy
 182
19:00 THE PREVALENCE, CLINICAL CHARACTERISTICS, AND PROGNOSIS OF 519 ELDERLY PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION.  A CLINICAL STUDY WITH A 5 YEARS FOLLOW-UP PERIOD
F. El Shaer, W. Hassan, N. ElKum, M. Fawzy, M. Nawaz, S. Khrabshah, N. AKhras, C. Canver, KFSH&RC, Saudi Arabia
 183
SUNDAY, JULY 29, 2007
16:45 - 19:30   HALL D
  S54  Session:
INTERVENTIONAL CARDIOLOGY
Chairpersons:    V. Mathew, Rochester, MN, USA 
                        H. Mudra, Munchen,
Germany
 
16:45 REDUCTION OF MYOINTIMAL HYPERPLASIA AFTER ARTERIAL ANASTOMOSIS BY LOCAL INJECTION OF TGF BETA 3
J. Ghosh, M.S. Baguneid, M.O. Murphy, N. Khwaja, N. Turner, A. Halka, A. Carter, M.W. Ferguson, C.M. Kielty, M.G.Walker, Manchester Royal Infirmary, UK
 184
17:00 EFFICACY AND SAFETY OF DOUBLE AND TRIPLE ANTIPLATELET THERAPY IN NON ST ELEVATION MYOCARDIAL INFARCTION
J.A. Marin-Neto, G.B. Marin, W.J. Rogers, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
 185
17:15 RENAL TOXICITY EVALUATION AND COMPARISON BETWEEN IODIXANOL AND HEXABRIX IN PATIENTS WITH RENAL INSUFFICIENCY UNDERGOING CORONARY ANGIOGRAPHY-THE RECOVER STUDY: A RANDOMIZED CONTROLLED TRIAL
S.H. Jo, H.S. Kim, B.K. Koo, T.J. Youn, H.J. Kang, Y.J. Kim, D.W. Sohn, B.H.Oh, Y.B. Park, Y.S. Choi, Hallym University Sacred Heart Hospital, Gyeonggi-do, Korea
 186
17:30 THE NORDIC BIFURCATION STUDY, 14 MONTHS DATA
T.K. Steigen, M. Maeng, R. Wiseth, A. Erglis, I. Kumsars, I. Narbute, P. Gunnes, J. Mannsverk, J.F. Lassen, L. Thuesen, University Hospital of Northern Norway, Tromsoe, Norway
 187
17:45 RENAL ANGIOPLASTY AND STENTING UNDER EMBOLIC PROTECTION DEVICES. A MUST? 
M. Henry, A.Polydorou, I.Henry, A. Polydorou, M.Hugel, Cabinet de Cardiologie, Nancy, France
 188
18:00 ENDOVASCULAR THERAPY OF CHRONIC MESENTERIC ISCHAEMIA
A.G. Daige, R.G. Wanderley, R.B. Favero, L.E. Pereira, I.S. Nunes, L.Z. Kanashiro, Santa Casa, Campo Grande, MS, Brazil
 189
18:15 BOTH SIDES CORONARY ANGIOGRAPHY AND INTERVENTION USING A SINGLE TRANSRADIAL GUIDING CATHETER
A.A. Youssef, Y.K. Hsieh, C.I. Cheng, C.J. Wu, Chang Gung University College of Medicine, Kaohsiung, Taiwan, R.O.C.
 190
18:30 Mid-term comparison between Drug Eluting Stents (DES) and surgical treatment of patients with Diabetes Mellitus
Y. Ben-Gal, B. Medalion, Y. Moshkovitz, I. Herz, N. Hansson, G. Uretzky, R. Mohr, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
 191
18:45 SAFETY AND EFFICACY OF TRIPLE ANTIPLATELET PHARMACOTHERAPY INCLUDING GLYCOPROTEIN IIB/IIIA RECEPTOR BLOCKERS IN ELDERLY PATIENTS RECEIVING DRUG-ELUTING STENTS
V.N. Singh, R.K. Sharma, M. Nelson, University of South Florida College of Medicine, Tampa, FL, USA
 192
19:00 ARE DRUG ELUTING STENTS SAFE IN THE ELDERLY?
M. Behan, G. Dixon, L. Blows, N. Pareek, D. Hildick-Smith, S. Holmberg,  A. deBelder, Sussex Cardiac Centre, Brighton, Sussex, UK
 193
19:15 PRIMARY AND RESCUE PERCUTANEOUS CORONARY INTERVENTION WITH PACLITAXEL-ELUTING STENT IMPLANTATION IN ST-ELEVATION MYOCARDIAL INFARCTION 
J.D. Schwalm, M. Ahmad, J.L. Velianou, C. Xie, M.K.  Natarajan, McMaster University, Hamilton General Hospital, Hamilton, ON, Canada
194


 

Sunday,
July 29, 2007
Monday,
July 30, 2007
Tuesday,
July 31, 2007
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions